King Wealth Management Group Has $1.17 Million Stake in UnitedHealth Group Incorporated $UNH

King Wealth Management Group reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 87.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,741 shares of the healthcare conglomerate’s stock after selling 26,307 shares during the period. King Wealth Management Group’s holdings in UnitedHealth Group were worth $1,167,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the business. Hibernia Wealth Partners LLC acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $207,000. Intrua Financial LLC grew its position in UnitedHealth Group by 30.8% during the second quarter. Intrua Financial LLC now owns 2,639 shares of the healthcare conglomerate’s stock worth $823,000 after buying an additional 622 shares in the last quarter. Schwarz Dygos Wheeler Investment Advisors LLC raised its holdings in UnitedHealth Group by 12.6% in the 2nd quarter. Schwarz Dygos Wheeler Investment Advisors LLC now owns 13,299 shares of the healthcare conglomerate’s stock valued at $4,149,000 after acquiring an additional 1,491 shares in the last quarter. Allianz SE grew its holdings in shares of UnitedHealth Group by 27.6% during the 2nd quarter. Allianz SE now owns 74,049 shares of the healthcare conglomerate’s stock worth $23,101,000 after purchasing an additional 16,016 shares in the last quarter. Finally, Good Life Advisors LLC increased its holdings in UnitedHealth Group by 396.7% in the 2nd quarter. Good Life Advisors LLC now owns 4,883 shares of the healthcare conglomerate’s stock valued at $1,524,000 after buying an additional 3,900 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 1.9%

Shares of NYSE:UNH opened at $332.53 on Friday. The business has a fifty day simple moving average of $347.53 and a 200 day simple moving average of $320.74. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $622.83. The firm has a market cap of $301.22 billion, a P/E ratio of 17.36, a P/E/G ratio of 2.28 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The company had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm’s revenue was up 12.2% compared to the same quarter last year. During the same period last year, the company earned $7.15 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Wall Street Analyst Weigh In

UNH has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target on the stock. in a research note on Wednesday, October 29th. Morgan Stanley boosted their target price on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. JPMorgan Chase & Co. lifted their price target on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Cantor Fitzgerald restated an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Finally, Bank of America increased their price target on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research note on Wednesday, October 8th. Eighteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.